UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 407

Sortiert nach

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension

The European respiratory journal, 2019-01, Vol.53 (1), p.1801906

2019

Volltextzugriff (PDF)

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Chest, 2012-08, Vol.142 (2), p.448-456

2012

Volltextzugriff (PDF)

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Chest, 2015-10, Vol.148 (4), p.1043-1054

2015

Volltextzugriff (PDF)

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

Chest, 2021-01, Vol.159 (1), p.337-346

2021

Volltextzugriff (PDF)

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies

Chest, 2019-08, Vol.156 (2), p.323-337

2019

Volltextzugriff (PDF)

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score

PloS one, 2020-11, Vol.15 (11), p.e0241504-e0241504

2020

Volltextzugriff (PDF)

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

Chest, 2012-02, Vol.141 (2), p.354-362

2012

Volltextzugriff (PDF)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

The European respiratory journal, 2019-06, Vol.53 (6), p.1802004

2019

Volltextzugriff (PDF)

World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

The Journal of heart and lung transplantation, 2012-09, Vol.31 (9), p.913-933

2012

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension: Epidemiology and Registries

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D51-D59

2013

Volltextzugriff (PDF)

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance

The Journal of heart and lung transplantation, 2015-03, Vol.34 (3), p.362-368

2015

Volltextzugriff (PDF)

Risk Assessment Tools in Pulmonary Arterial Hypertension. Prognosis for Prospective Trials?

American journal of respiratory and critical care medicine, 2018-04, Vol.197 (7), p.843-845

2018

Volltextzugriff (PDF)

Ethical considerations of thoracic transplant and circulatory support during the COVID-19 pandemic: A closer look at pulmonary vascular disease

The Journal of heart and lung transplantation, 2020-08, Vol.39 (8), p.852-853

2020

Volltextzugriff (PDF)

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review

The Journal of heart and lung transplantation, 2021-03, Vol.40 (3), p.172-182

2021

Volltextzugriff (PDF)

Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension

Journal of the American College of Cardiology, 2009-06, Vol.54 (1), p.S67-S77

2009

Volltextzugriff (PDF)

Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

Circulation (New York, N.Y.), 2010-07, Vol.122 (2), p.164-172

2010

Volltextzugriff (PDF)

Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial

Chest, 2023-12, Vol.164 (6), p.1518-1530

2023

Volltextzugriff (PDF)

Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.300-309

2020

Volltextzugriff (PDF)

Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design

Respiratory research, 2022-12, Vol.23 (1), p.355-355, Article 355

2022

Volltextzugriff (PDF)

Risk stratification in pulmonary arterial hypertension using Bayesian analysis

The European respiratory journal, 2020-08, Vol.56 (2), p.2000008

2020

Volltextzugriff (PDF)

National trends and inpatient outcomes of pulmonary arterial hypertension related hospitalizations – Analysis of the National Inpatient Sample Database

International journal of cardiology, 2020-11, Vol.319, p.131-138

2020

Volltextzugriff (PDF)

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis

The Journal of heart and lung transplantation, 2015-03, Vol.34 (3), p.356-361

2015

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry

Chest, 2010-02, Vol.137 (2), p.376-387

2010

Volltextzugriff (PDF)

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized Controlled Clinical Trial

Journal of the American College of Cardiology, 2010-05, Vol.55 (18), p.1915-1922

2010

Volltextzugriff (PDF)

Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

The Journal of heart and lung transplantation, 2021-10, Vol.40 (10), p.1172-1180

2021

Volltextzugriff (PDF)

1 – 25 von 407

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(232)
Life Sciences & Biomedicine
(228)
Humans
(182)
Respiratory System
(134)
Cardiovascular System & Cardiology
(131)
Cardiac & Cardiovascular Systems
(123)
Female
(103)
Male
(103)
Middle Aged
(95)
Pulmonary Arterial Hypertension
(92)
Pulmonary Hypertension
(82)
Adult
(74)
Biological And Medical Sciences
(70)
Medical Sciences
(70)
Transplantation
(64)
Surgery
(63)
Aged
(57)
General & Internal Medicine
(45)
Hypertension, Pulmonary - Physiopathology
(39)
Cardiology. Vascular System
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score

The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult—a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

Pulmonary Arterial Hypertension: Epidemiology and Registries

Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance

Risk Assessment Tools in Pulmonary Arterial Hypertension. Prognosis for Prospective Trials?

Ethical considerations of thoracic transplant and circulatory support during the COVID-19 pandemic: A closer look at pulmonary vascular disease

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review

Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension

Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)

Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial

Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study

Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design

Risk stratification in pulmonary arterial hypertension using Bayesian analysis

National trends and inpatient outcomes of pulmonary arterial hypertension related hospitalizations – Analysis of the National Inpatient Sample Database

Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis

Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized Controlled Clinical Trial

Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Aktive Filter

Suchergebnisse filtern